IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 401.50K | 341.40K | 1.23M | 889.80K | 718.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 401.50K | 341.40K | 1.23M | 889.80K | 718.20K |
| Operating Income | -401.50K | -341.40K | -1.23M | -889.80K | -718.20K |
| Income Before Tax | -343.30K | -2.79M | 1.18M | -3.33M | 731.00K |
| Income Tax Expenses | 0.00 | -4.20K | -- | -- | -- |
| Earnings from Continuing Operations | -343.30K | -2.79M | 1.18M | -3.33M | 731.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -343.30K | -2.79M | 1.18M | -3.33M | 731.00K |
| EBIT | -401.50K | -341.40K | -1.23M | -889.80K | -718.20K |
| EBITDA | -399.70K | -339.40K | -1.22M | -887.50K | -715.50K |
| EPS Basic | -0.01 | -0.18 | 0.08 | -0.24 | 0.05 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.07 | -0.06 | -0.06 |
| EPS Diluted | -0.01 | -0.18 | 0.08 | -0.24 | 0.05 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.07 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 17.10M | 16.83M | 15.31M | 13.89M | 13.39M |
| Average Diluted Shares Outstanding | 17.10M | 16.83M | 15.31M | 13.89M | 13.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |